LifeStance Health Gr Q2 EPS $(0.13) Misses $(0.09) Estimate, Sales $259.58M Beat $255.15M Estimate
Portfolio Pulse from Benzinga Newsdesk
LifeStance Health Gr (NASDAQ:LFST) reported Q2 EPS of $(0.13), missing the analyst consensus estimate of $(0.09) by 44.44%. However, the company's quarterly sales of $259.58M beat the estimate of $255.15M by 1.74%. This represents a 23.89% increase over sales from the same period last year.
August 09, 2023 | 10:02 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
LifeStance's Q2 EPS missed estimates by 44.44%, but sales exceeded expectations by 1.74% and increased 23.89% YoY.
LifeStance's Q2 earnings per share (EPS) missed analyst estimates, which could negatively impact the stock. However, the company's sales beat estimates and showed strong year-over-year growth, which could offset the negative impact of the EPS miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100